What Researchers Did
Researchers reviewed the current knowledge and therapeutic applications of hyperbaric oxygen therapy in ophthalmology.
What They Found
The review found increasing evidence supporting the safety and efficacy of hyperbaric oxygen therapy for several eye conditions. These include retinal artery occlusion, cystoid macular oedema secondary to retinal vein occlusion, scleral thinning, orbital rhino-cerebral mucormycosis, nonhealing corneal oedema, and anterior segment ischaemia.
What This Means for Canadian Patients
Canadian patients with certain acute or chronic eye disorders might benefit from hyperbaric oxygen therapy, especially for conditions like retinal artery occlusion or nonhealing corneal oedema. While currently an off-label treatment for eye diseases, its potential efficacy suggests it could become a more recognised option in the future.
Canadian Relevance
This review article has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.
Study Limitations
As a review, this study summarizes existing evidence without presenting new primary research data or clinical trial outcomes.